Case Reports
doi: 10.1080/10428190601059704.
Fulminant B hepatitis in a surface antigen and hepatitis B DNA-negative patient with diffuse large B-cell lymphoma after CHOP chemotherapy plus rituximab
- PMID: 17325912
- DOI: 10.1080/10428190601059704
Item in Clipboard
Case Reports
Fulminant B hepatitis in a surface antigen and hepatitis B DNA-negative patient with diffuse large B-cell lymphoma after CHOP chemotherapy plus rituximab
Leuk Lymphoma.
2007 Feb.
No abstract available
Similar articles
-
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.N Engl J Med. 2002 Jan 24;346(4):235-42. doi: 10.1056/NEJMoa011795. N Engl J Med. 2002. PMID: 11807147 Clinical Trial.
-
Immunochemotherapy is the standard of care in elderly patients with diffuse large B-cell lymphoma.Blood. 2004 Sep 1;104(5):1584-5; author reply 1585-6. doi: 10.1182/blood-2004-04-1266. Blood. 2004. PMID: 15317734 No abstract available.
-
Delayed hepatitis B virus reactivation after cessation of preemptive lamivudine in lymphoma patients treated with rituximab plus CHOP.Ann Hematol. 2004 Dec;83(12):769-74. doi: 10.1007/s00277-004-0899-y. Epub 2004 Aug 25. Ann Hematol. 2004. PMID: 15338194
-
[Treatment of diffuse large B-cell lymphoma].Dtsch Med Wochenschr. 2008 Sep;133(36):1785-94; quiz 1795-6. doi: 10.1055/s-0028-1082813. Epub 2008 Sep 2. Dtsch Med Wochenschr. 2008. PMID: 18767006 Review. German.
-
Lenalidomide Maintenance after R-CHOP Therapy in Diffuse Large B-Cell Lymphoma: Can It Be a Standard of Care.Acta Haematol. 2017;138(4):216-220. doi: 10.1159/000484515. Epub 2017 Dec 7. Acta Haematol. 2017. PMID: 29212067 Review.
Cited by
-
Prevention and management of hepatitis B virus reactivation in patients with hematological malignancies treated with anticancer therapy.World J Gastroenterol. 2016 Jul 28;22(28):6484-500. doi: 10.3748/wjg.v22.i28.6484. World J Gastroenterol. 2016. PMID: 27605883 Free PMC article. Review.
-
A case of hepatitis B reactivation in an anti-HBs positive, anti-HBc positive non-Hodgkin's lymphoma patient.Virol Sin. 2013 Feb;28(1):49-52. doi: 10.1007/s12250-013-3285-x. Epub 2013 Feb 6. Virol Sin. 2013. PMID: 23385354 Free PMC article. No abstract available.
-
Preventing hepatitis B reactivation in immunosuppressed patients: is it time to revisit the guidelines?Arthritis Care Res (Hoboken). 2010 May;62(5):585-9. doi: 10.1002/acr.20167. Arthritis Care Res (Hoboken). 2010. PMID: 20191573 Free PMC article. No abstract available.
-
The management of chronic hepatitis B in Asian Americans.Dig Dis Sci. 2011 Nov;56(11):3143-62. doi: 10.1007/s10620-011-1841-5. Epub 2011 Sep 21. Dig Dis Sci. 2011. PMID: 21935699 Review.
-
HBV treatment in a patient who will be receiving immunosuppressive therapy.Clin Liver Dis (Hoboken). 2013 Mar 1;2(1):34-37. doi: 10.1002/cld.157. eCollection 2013 Feb. Clin Liver Dis (Hoboken). 2013. PMID: 30992818 Free PMC article. Review. No abstract available.
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical
Research Materials
